Sessions are scheduled in Singapore Time (SGT)

Displaying One Session

Time
12:45 - 14:15

Welcome and opening

Current management of NSCLC in Asia Pacific

What’s new in the management of non-mutated NSCLC after progression to immunotherapy treatment

Defining optimal sequencing in HCC with evidence and experience-based discussion

How can we further optimize the management of RCC patients

Panel discussion and closing